Skip to main content
SpringerLink
Log in

The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

5-HT3 receptors are abundant in central dopamine (DA) terminal areas. They do not affect basal DA turnover but appear to modulate DA release by e.g. morphine and nicotine. The interpretation of these findings is uncertain, and it is unclear whether 5-HT3 receptors also influence the activity of compounds such as amphetamine and cocaine, which act more directly on the DA synapse. Variable-interval (VI), threshold-current hypothalamic self-stimulation can provide a continuous index of central dopaminergic activity, but is relatively insensitive to changes in 5-HT and thus offers a means of investigating this question. In the present study, a selective 5-HT3 receptor antagonist, ondansetron (GR 38032F) (1.0 to 1000 μg/kg sc), had no effect on VI self-stimulation, nor did a 100 μg/kg dose affect facilitation of responding byd-amphetamine (500 jig/kg ip). Ondansetron (100 μg/kg) reduced the initial depression of self-stimulation by high-dose nicotine (400 μg/kg), but not the ensuing facilitation. Similar results were obtained in rats “sensitized” to nicotine by prior chronic exposure. These results support the proposal that 5-HT3 receptors, normally quiescent under basal conditions, mediate the excitatory effect of compounds acting upstream from the DA neuron, such as nicotine, but do not affect the dopaminergic synapse directly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acquas E, Carboni E, Garau L, Di Chiara G (1990) Blockade of acquisition of drug-conditioned place aversion by 5-HT3 antagonists. Psychopharmacology 100: 459–463

    Google Scholar 

  • Bialajew C, Shizgal P (1986) Evidence implicating descending fibres in self-stimulation of the medial forebrain bundle. J Neurosci 6: 919–929

    Google Scholar 

  • Blandina P, Goldfarb J, Craddock-Royal B, Green JP (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J Pharmacol Exp Ther 251: 803–809

    Google Scholar 

  • Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94: 397–412

    Google Scholar 

  • Carboni E, Acquas E, Frau R, Di Chiara G (1989a) Differential effects of 5-HT3 antagonists on drug-induced stimulation of dopamine release. Eur J Pharmacol 164: 515–519

    Google Scholar 

  • Carboni E, Acquas E, Leone P, Di Chiara G (1989b) 5-HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 97: 175–178

    Google Scholar 

  • Chen J, Van Praag HM, Gardner EL (1991) Activation of 5-HT3 receptor by 1-phenyl-biguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543: 354–357

    Google Scholar 

  • Clarke PBS (1990) Mesolimbic dopamine activation — the key of nicotine reinforcement? In: Bock G, Marsh J (eds) The biology of nicotine dependence. Ciba Symposium 152. Wiley Chichester

    Google Scholar 

  • Clarke PBS, Kumar R (1983) The effects of nicotine in non-tolerant and tolerant rats. Br J Pharmacol 78: 329–3374

    Google Scholar 

  • Costall B, Domeney AM, Naylor RJ (1982) Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat. Neuropharmacology 21: 327–335

    Google Scholar 

  • Costall B, Domeney AM, Naylor RJ (1983) A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections. Naunyn Schmiedebergs Arch Pharmacol 324: 27–33

    Google Scholar 

  • Costall B, Domeney AM, Naylor RJ, Tyers NB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92: 881–894

    Google Scholar 

  • Costall B, Naylor RJ, Tyers MB (1988) Recent advances in the neuropharmacology of 5-HT3 agonists and antagonists. Rev Neurosci 2: 41–65

    Google Scholar 

  • Domeney AM, Costall B, Gerrard PA, Jones DNC, Naylor TJ, Tyers MB (1992) The effect of ondansetron on cognitive performance in the marmoset. Pharmacol Biochem Behav 38: 169–175

    Google Scholar 

  • Hagan RM, Jones BJ, Jordan CC, Tyers MB (1990) Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br J Pharmacol 99: 227–232

    Google Scholar 

  • Herberg LJ, Rose IC (1990) Excitatory amino acid pathways in brain-stimulation reward. Behav Brain Res 39: 230–239

    Google Scholar 

  • Herberg LJ, Stephens DN, Franklin KBJ (1976) Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacol Biochem Behav 4: 575–582

    Google Scholar 

  • Herberg LJ, de Belleroche JS, Rose IC, Montgomery AMJ (1992) Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK-analogue caerulein. Neurosci Lett 140: 16–18

    Google Scholar 

  • Higgins GA, Joharchi N, Nguyen P, Sellers EM (1992) Effect of the 5-HT3 receptor antagonists, MDL 72222 and ondansetron on morphine place conditioning. Psychopharmacology 106: 315–320

    Google Scholar 

  • Jiang LH, Ashby CR Jr, Kasser RJ, Wang RY (1990) The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res 513: 156–160

    Google Scholar 

  • Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potental anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93: 985–993

    Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330: 746–748

    Google Scholar 

  • Kilpatrick GJ, Bunce KT, Tyers MB (1990) 5-HT3 receptors. Med Res Rev 10: 441–475

    Google Scholar 

  • Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paule B, Paes D, Bons J (1990) Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 322: 816–821

    Google Scholar 

  • Moore KE, Chiueh CC, Zeldes G (1977) Release of neurotransmitters from the brain in vivo by amphetamine, methylphenidate and cocaine. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Plenum Press, New York, pp 143–160

    Google Scholar 

  • O'Neill MF, Dourish CT, Iversen SD (1991) Evidence for an involvement of D 1 and D 2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology 104: 343–350

    Google Scholar 

  • Paris JM, Cunningham KA (1991) Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology 104: 475–478

    Google Scholar 

  • Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York

    Google Scholar 

  • Peltier R, Schenk S (1991) GR 38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol Biochem Behav 39: 133–136

    Google Scholar 

  • Rose IC, Mintz M, Herberg LJ (1988) Chronic l-dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol. Pharmacol Biochem Behav 30: 585–588

    Google Scholar 

  • Schaefer GJ, Michael RP (1992) Schedule-controlled brain stimulation: has it utility for behavioural pharmacology? Neurosci Biobehav Rev (in press)

  • van der Hoek GA, Cooper SJ (1990a) Antagonism of amphetamine-induced sniffing, but not hyperlocomotion, by the selective 5-HT3 antagonist, ondansetron. Br J Pharmacol 100: 414P

  • van der Hoek GA, Cooper SJ (1990b) Evidence that ondansetron, a selective 5-HT3 antagonist, reduces cocaine's psychomotor stimulant effects in the rat. Psychopharmacology 101: S 59 (Abstr)

    Google Scholar 

  • Wettstein JG, Junien J-L (1992) Effect of 5-HT3 antagonists on fixed-interval behaviour in rats. Pharmacol Biochem Behav 41: 659–662

    Google Scholar 

  • White A, Corn TH, Feetham C, Faulconbridge C (1991) Ondansetron in the treatment of schizophrenia. Lancet 337: 1173

    Google Scholar 

  • Wise RA (1978) Catecholamine theories of reward: a critical review. Brain Res 152: 215–247

    Google Scholar 

  • Wozniak KM, Pert A, Linnoila M (1990) Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine. Eur J Pharmacol 187: 287–289

    Google Scholar 

Download references

Author information

Author notes

  1. A. M. J. Montgomery

    Present address: Department of Psychology, City of London Polytechnic, London E1, UK

Authors and Affiliations

  1. Institute of Neurology, Queen Square, London, UK

    A. M. J. Montgomery, I. C. Rose & L. J. Herberg

Authors
  1. A. M. J. Montgomery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. C. Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. J. Herberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montgomery, A.M.J., Rose, I.C. & Herberg, L.J. The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission. J. Neural Transmission 91, 1–11 (1993). https://doi.org/10.1007/BF01244914

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244914

Keywords

Search

Navigation